It is observed that SORL1 levels are reduced in AD-diseased brain, while overexpression of it redistributes APP to the Golgi apparatus; thus, the placement and interaction time of APP and BACE1 is reduced in the early endosomes, which will reduce the amount of Aβ42. Here, BACE1 is linked to Alzheimer disease.